ALEXANDRA DANIEL: Open Payments
NPI 1760990915 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 72 payments from 23 companies in 2025. Trend: 2023 $71 · 2024 $1,421 · 2025 $1,525
Food & beverage: $1,455Education: $70
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $228 |
| Amgen Inc. | 13 | $216 |
| Lilly USA, LLC | 9 | $126 |
| SANOFI-AVENTIS U.S. LLC | 4 | $125 |
| Corcept Therapeutics | 3 | $93 |
| Sequel Med Tech, LLC | 3 | $67 |
| Tandem Diabetes Care, Inc. | 2 | $64 |
| Mannkind Corporation | 3 | $64 |
| BETA BIONICS, INC. | 3 | $59 |
| Globus Medical, Inc. | 1 | $56 |
Products named: Veozah, TEPEZZA, TZIELD, Korlym, ZEPBOUND, TWIIST, t:slim X2 Insulin Pump with Control-IQ, AFREZZA.
Industry payments across GA — which companies pay providers there.
